Search Log in
Rare Disease and Orphan Drugs Journal
Open Access  ISSN: 2771-2893 (Online)   Editor-in-Chief: Daniel Scherman
Indexing: Dimensions, Lens,
MPT: 96 days
Home Articles Special Issues Volumes Webinars Videos
Home Articles Special Issues Volumes Webinars Videos
It has reached the top

Editorial Board Member

Olivier Blin
Service de Pharmacologie Clinique et Pharmacovigilance, Aix-Marseille University, AP-HM, Orphandev-FCRIN, INSERM, Marseille, France.
HomePage
https://www.neuroservices-alliance.com/member/olivier-blin/
Research Interests
Neurodegenerative disorders and aging
Contributions:

Rare diseases: specific challenges for sustainable accessibility of treatments for patients

2017-2023: state of the art of gene therapies in rare diseases in Europe: the dynamics of clinical R&D, new approved treatments and expected therapies in the pipelines

Special Issue:

Gene Therapy in Rare Diseases

Submit a Manuscript
Manuscript Templates
Aims and Scope
Editorial Board
Submit a Manuscript
Manuscript Templates
Aims and Scope
Editorial Board
Rare Disease and Orphan Drugs Journal
ISSN 2771-2893 (Online)
Navigation
Follow Us
Navigation

Committee on Publication Ethics

https://publicationethics.org/members/rare-disease-and-orphan-drugs-journal

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Committee on Publication Ethics

https://publicationethics.org/members/rare-disease-and-orphan-drugs-journal

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/
Privacy Cookies Terms of Service Contact Us
Contact Us
partners@oaepublish.com
Follow OAE
Twitter
Facebook
LinkedIn
YouTube
BiLiBiLi
WeChat
© 2016-2023 OAE Publishing Inc., except certain content provided by third parties